跳至主要内容
临床试验/NCT00536458
NCT00536458已完成3 期

Phase III Study of Treatment of Localized Lymphomas: Radiotherapy Versus Radio-Chemotherapie

French Innovative Leukemia Organisation1 个研究点 分布在 1 个国家目标入组 132 人开始时间: 1999年3月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
132
试验地点
1
主要终点
failure free survival at 5 years

研究概览

简要总结

To compare localiezd radiotherapy to localized radiotherapy followed by 6 cycles of chemotherapy in the treatment of localiezd low grade lymphoma

详细描述

The standard treatment ol localized low grade lymphomas is Radiotherapy alone can offer long term remissions to some patients .

No study have clearly demonstrated the interest of chemotherapy. The purpose of the study is to determine wether prednisone administrated after first line local radiotherapy (30 GY) can pre in the treatment of localized low grade lymphomas of adult patients

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 79 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Low grade lymphoma defined according to the Ann Arbor classification
  • localized

排除标准

  • Subjects unable to signed informed consent
  • Pregnancy

研究组 & 干预措施

radiotherapy

Experimental

minichep + radiotherapy

干预措施: radiotherapy (Procedure)

B

Active Comparator

MINI CHEP

干预措施: MINI CHEP (Drug)

结局指标

主要结局

failure free survival at 5 years

时间窗: 5 years

次要结局

  • overall survival at 5 years(5 years)
  • response rates at the end of the treatment(6 months)
  • prognstic value of molecular analyses in blood and marrow(6 months)

研究者

发起方
French Innovative Leukemia Organisation
申办方类型
Other

研究点 (1)

Loading locations...

相似试验